Skip to main content
Carasent logo

Carasent — Investor Relations & Filings

Ticker · CARA ISIN · NO0010123060 LEI · 5967007LIEEXZXI9ZS60 OL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 635 across all filing types
Latest filing 2024-10-21 Call Transcript
Country NO Norway
Listing OL CARA

About Carasent

https://carasent.com/

Carasent is a health technology group focused on enhancing efficiency and quality in the healthcare sector. The company develops and provides mission-critical, cloud-based software solutions, with a primary focus on Electronic Health Record (EHR) and Electronic Medical Record (EMR) systems, often delivered as Software as a Service (SaaS). With over 30 years of experience, Carasent also offers a suite of integrated ecosystem services designed to automate and streamline clinical and administrative workflows. By integrating its core platforms with proprietary and third-party applications, the company creates seamless processes that reduce administrative burdens for customers in the healthcare, rehabilitation, and occupational health sectors.

Recent filings

Filing Released Lang Actions
Carasent ASA - Invitation to presentation of Q3 2024 results
Call Transcript Classification · 95% confidence The document is very short (924 characters) and explicitly serves as an 'Invitation to presentation of Q3 2024 results'. It announces the date (24 October) and time for a webcast and teleconference where the Q3 2024 financial results will be presented, including a Q&A session. This structure—announcing the event where the results will be discussed—is characteristic of a Call Transcript announcement or an Earnings Release announcement, but since it is primarily an invitation to listen to the results presentation rather than the release of the results themselves or the transcript, it fits best as an announcement related to the earnings call. Given the options, the closest fit for an announcement about an upcoming earnings presentation/call is often grouped with the Call Transcript (CT) or Earnings Release (ER). However, since it is an invitation to a presentation/webcast where results will be discussed, and it provides links for access, it strongly suggests the event that will generate a Call Transcript (CT). If the document were the actual transcript, it would be much longer. If it were the ER, it would contain the key figures. Since it is an invitation to the event, it is an announcement related to the call. Given the options, and the focus on the presentation/webcast access, it is most closely related to the event that generates a Call Transcript (CT). Alternatively, if the system prioritizes announcements about results presentations, it could be seen as a precursor to an ER or CT. Given the explicit mention of a webcast/teleconference with Q&A, CT is the most appropriate category for the event being announced.
2024-10-21 English
Carasent ASA - Invitation to presentation of Q3 2024 results
Report Publication Announcement Classification · 98% confidence The document is titled 'Carasent ASA - Invitation to presentation of Q3 2024 results' and explicitly invites participants to a webcast and teleconference for the presentation of the Q3 2024 financial results. This is a classic announcement about an upcoming event where results will be discussed, not the results document itself (like an ER or IR). Since the document is short and serves to announce the timing and access details for a results presentation/call, it fits the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports/events.
2024-10-21 English
Carasent ASA Certain practical information to shareholders in connection with contemplated relisting to Nasdaq Stockholm
Regulatory Filings Classification · 99% confidence The document is written in Norwegian and details instructions for shareholders of Carasent ASA regarding a cross-border merger into Carasent AB and the subsequent relisting of shares from Oslo Børs to Nasdaq Stockholm. It focuses heavily on the administrative steps shareholders must take to ensure their shares are held in a Swedish-compatible account to trade on the new exchange, including details about secondary registration and a period for cost-free re-registration. This type of communication, which explains a significant corporate action (merger/relisting) and provides procedural guidance to investors, is typically classified as a general corporate action announcement or investor information. Since it is not a formal regulatory filing like a 10-K, an earnings release (ER), or a proxy statement (DEF 14A), and it is not a presentation (IP) or a transcript (CT), the most fitting category is 'Regulatory Filings' (RNS) as a general announcement related to corporate structure changes, or potentially 'Capital/Financing Update' (CAP) due to the share structure change, but RNS serves as a better catch-all for detailed procedural notices about structural changes not covered by other specific codes. Given the context of a major corporate restructuring and shareholder notification, RNS is the most appropriate general classification.
2024-10-04 Norwegian
Carasent ASA Certain practical information to shareholders in connection with contemplated relisting to Nasdaq Stockholm
Regulatory Filings Classification · 99% confidence The document discusses a 'cross-border merger' of Carasent ASA into Carasent AB and the subsequent 'relisting' of shares from Oslo Børs to Nasdaq Stockholm. It provides detailed instructions to shareholders on how to manage their accounts to hold Swedish-listed shares, including deadlines and procedures for transferring shares or dealing with 'secondary recorded' shares. This content is highly specific to a corporate restructuring event involving a change in listing venue and shareholder action, which falls under the scope of corporate actions related to capital structure or significant corporate events. While it touches upon financing/capital structure (CAP), the primary focus is communicating the mechanics of a merger and relisting to existing shareholders, which is often communicated via a specific regulatory filing or a detailed investor communication. Given the nature of the transaction (merger and relisting) and the detailed shareholder guidance, it strongly suggests a document related to a significant corporate transaction. Since there isn't a specific code for 'Merger Information' or 'Relisting Notice', the closest fit among the provided options that covers significant corporate structural changes and shareholder impact is 'Capital/Financing Update' (CAP) or potentially 'Regulatory Filings' (RNS) if it were a formal exchange filing. However, the content is an informational guide about the mechanics of the merger and share transfer, not a formal financial report (10-K, IR) or a simple announcement (RPA). Given the context of a merger leading to a change in listing, 'TAR' (M&A Activity) is a possibility, but this document is post-announcement, focusing on execution. Since the core event is a structural change affecting capital/shares, 'CAP' is the most appropriate classification for detailed execution instructions following a merger/relisting, as it directly impacts the capital structure and share trading mechanism. I will classify it as CAP.
2024-10-04 English
Carasent ASA Certain practical information to shareholders in connection with contemplated relisting to Nasdaq Stockholm
Delisting Announcement Classification · 100% confidence The document is very short (1289 characters) and explicitly states that it is publishing 'attached practical information to shareholders in preparation of the contemplated Relisting' following an extraordinary general meeting approval of a merger plan. It directs the reader to attachments (PDFs) for the detailed information. This structure—a brief announcement pointing to a detailed document—fits the definition of a Report Publication Announcement (RPA), as per the 'MENU VS MEAL' rule, rather than classifying it as the underlying M&A or Capital/Financing document itself. The core event is the announcement of the publication of shareholder information related to a merger/relisting.
2024-10-04 English
Carasent ASA Certain practical information to shareholders in connection with contemplated relisting to Nasdaq Stockholm
Delisting Announcement Classification · 100% confidence The document is very short (1104 characters) and explicitly states that it is publishing 'the attached practical information to shareholders in preparation of the contemplated Relisting' (a merger/relisting event). This structure—a brief announcement pointing to attached or linked material—strongly suggests it is an announcement about the publication of information rather than the full report itself. The content relates to a corporate action (relisting/merger) and provides practical shareholder information. Since there is no specific code for 'Relisting Information' and the document is an announcement of attached material, the most appropriate classification is Report Publication Announcement (RPA), as it announces the release of necessary shareholder documentation related to the corporate action. It is not a general regulatory filing (RNS) because it is specifically announcing the publication of preparatory materials for a known event.
2024-10-04 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.